471 related articles for article (PubMed ID: 24282073)
1. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
Lee TW; Southern KW
Cochrane Database Syst Rev; 2013 Nov; (11):CD005599. PubMed ID: 24282073
[TBL] [Abstract][Full Text] [Related]
2. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
Lee TW; Southern KW
Cochrane Database Syst Rev; 2012 Oct; 10():CD005599. PubMed ID: 23076917
[TBL] [Abstract][Full Text] [Related]
3. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
Lee TW; Southern KW; Perry LA; Penny-Dimri JC; Aslam AA
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD005599. PubMed ID: 27314455
[TBL] [Abstract][Full Text] [Related]
4. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
Lee T; Southern KW
Cochrane Database Syst Rev; 2007 Apr; (2):CD005599. PubMed ID: 17443603
[TBL] [Abstract][Full Text] [Related]
5. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW
Cochrane Database Syst Rev; 2015 Mar; (3):CD009841. PubMed ID: 25811419
[TBL] [Abstract][Full Text] [Related]
6. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
Southern KW; Patel S; Sinha IP; Nevitt SJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
[TBL] [Abstract][Full Text] [Related]
7. Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis.
Aslam AA; Higgins C; Sinha IP; Southern KW
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD012040. PubMed ID: 28102546
[TBL] [Abstract][Full Text] [Related]
8. Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis.
Aslam AA; Sinha IP; Southern KW
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD012040. PubMed ID: 36866921
[TBL] [Abstract][Full Text] [Related]
9. Airway clearance techniques compared to no airway clearance techniques for cystic fibrosis.
Warnock L; Gates A
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD001401. PubMed ID: 37042825
[TBL] [Abstract][Full Text] [Related]
10. Oscillating devices for airway clearance in people with cystic fibrosis.
Morrison L; Innes S
Cochrane Database Syst Rev; 2017 May; 5(5):CD006842. PubMed ID: 28471492
[TBL] [Abstract][Full Text] [Related]
11. Oscillating devices for airway clearance in people with cystic fibrosis.
Morrison L; Milroy S
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD006842. PubMed ID: 32352564
[TBL] [Abstract][Full Text] [Related]
12. Autogenic drainage for airway clearance in cystic fibrosis.
McCormack P; Burnham P; Southern KW
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009595. PubMed ID: 28984368
[TBL] [Abstract][Full Text] [Related]
13. Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis.
McIlwaine M; Button B; Dwan K
Cochrane Database Syst Rev; 2015 Jun; (6):CD003147. PubMed ID: 26083308
[TBL] [Abstract][Full Text] [Related]
14. Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis.
Lands LC; Stanojevic S
Cochrane Database Syst Rev; 2016 Apr; 4():CD001505. PubMed ID: 27055154
[TBL] [Abstract][Full Text] [Related]
15. Oscillating devices for airway clearance in people with cystic fibrosis.
Morrison L; Agnew J
Cochrane Database Syst Rev; 2014 Jul; (7):CD006842. PubMed ID: 25038719
[TBL] [Abstract][Full Text] [Related]
16. Dornase alfa for cystic fibrosis.
Yang C; Chilvers M; Montgomery M; Nolan SJ
Cochrane Database Syst Rev; 2016 Apr; 4():CD001127. PubMed ID: 27043279
[TBL] [Abstract][Full Text] [Related]
17. Inhaled mannitol for cystic fibrosis.
Nolan SJ; Thornton J; Murray CS; Dwyer T
Cochrane Database Syst Rev; 2015 Oct; (10):CD008649. PubMed ID: 26451533
[TBL] [Abstract][Full Text] [Related]
18. Autogenic drainage for airway clearance in cystic fibrosis.
Burnham P; Stanford G; Stewart R
Cochrane Database Syst Rev; 2021 Dec; 12(12):CD009595. PubMed ID: 34910295
[TBL] [Abstract][Full Text] [Related]
19. Respiratory muscle training for cystic fibrosis.
Stanford G; Ryan H; Solis-Moya A
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD006112. PubMed ID: 33331663
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic enzyme replacement therapy for people with cystic fibrosis.
Somaraju UR; Solis-Moya A
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD008227. PubMed ID: 27878805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
